Cystic hygroma is a rare congenital malformation caused by abnormal development of lymphatic vessels. It is usually diagnosed during pregnancy, often in the second trimester. The condition is characterized by a fluid-filled sac that is located in the neck, chest, or abdomen. Cystic hygroma can cause a variety of symptoms, including difficulty breathing, respiratory distress, and even cardiac problems. Ultrasound is the primary imaging modality used to diagnose cystic hygroma, as it can provide detailed images of the affected area. In this article, we will discuss the ultrasound features of cystic hygroma, as well as the implications for patient care.
Cystic hygroma is a rare congenital malformation caused by abnormal development of lymphatic vessels. It is usually diagnosed during pregnancy, often in the second trimester. The condition is characterized by a fluid-filled sac that is located in the neck, chest, or abdomen. Cystic hygroma can cause a variety of symptoms, including difficulty breathing, respiratory distress, and even cardiac problems.
Ultrasound is the primary imaging modality used to diagnose cystic hygroma, as it can provide detailed images of the affected area. On ultrasound, cystic hygroma appears as a large, fluid-filled cyst with a thin wall. The cyst may be located in the neck, chest, or abdomen. It may also be associated with other anomalies, such as cardiac defects or skeletal abnormalities. The size of the cyst can vary, but it is typically larger than 5 cm in diameter. It may also have septations, which are thin walls that divide the cyst into smaller compartments. The cyst may also contain debris, which may appear as echogenic material on ultrasound.
The diagnosis of cystic hygroma has important implications for patient care. If the condition is detected during pregnancy, the patient should be closely monitored for any signs of respiratory distress or cardiac problems. In addition, the patient should be referred to a specialist for further evaluation and management. If cystic hygroma is detected after birth, the patient should be referred to a specialist for further evaluation and management. Treatment may include surgical removal of the cyst or drainage of the cyst with a needle. In some cases, medications may be used to reduce the size of the cyst.
Cystic hygroma is a rare congenital malformation caused by abnormal development of lymphatic vessels. Ultrasound is the primary imaging modality used to diagnose cystic hygroma, as it can provide detailed images of the affected area. The diagnosis of cystic hygroma has important implications for patient care, and patients should be referred to a specialist for further evaluation and management. Treatment may include surgical removal of the cyst or drainage of the cyst with a needle, as well as medications to reduce the size of the cyst.
1.
Breast density changes over time are associated with an increased risk of cancer.
2.
How the metastasis of cancer is driven by cellular plasticity.
3.
Belzutifan Combo Could be Second-Line Option in Advanced RCC
4.
Radioligand Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer
5.
Research indicates that extended PSMA therapy is safe and effective for patients with prostate cancer.
1.
Essential Oncology Updates: Diagnosis, Treatment Advances, Tools & Education Resources
2.
Unlocking the Secrets of Hemoglobin: How It Works to Keep Us Healthy
3.
Uncovering the Mystery of the Sessile Serrated Adenoma
4.
Biomimetic Nanovesicles Target Senescent-Escape Cancer Stem Cells in Breast Cancer
5.
The Science Behind Thrombolytic Drugs and Their Benefits
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
5.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation